AVADEL PHARMACEUTICALS PLC·4

Mar 7, 4:09 PM ET

Seurer Jerad G. 4

4 · AVADEL PHARMACEUTICALS PLC · Filed Mar 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-05
Seurer Jerad G.
Gen. Counsel & Corp. Secretary
Transactions
  • Award

    Ordinary Shares

    2025-03-05+14,70023,495 total
  • Award

    Stock Option (Right to Buy)

    2025-03-05+84,00084,000 total
    Exercise: $7.87Exp: 2030-03-06Ordinary Shares (84,000 underlying)
Footnotes (2)
  • [F1]Consists of a restricted share award. The restricted share award shall vest in equal annual installments on each of the first four anniversaries following the 3/5/2025 grant date.
  • [F2]The options shall vest, if at all, in four equal increments if the volume-weighted average price of the Issuer's Ordinary Shares during any 30 calendar day period exceeds $11, $14, $17 and $19.09, respectively.

Documents

1 file
  • 4
    tm258534-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT